Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Novel approach to enhancing antitumor immunity with dendritic cell-based vaccines

March 12, 2002

AltaRex initiates OvaRex pharmacokinetic study

March 8, 2002

Encouraging results of DCVax-Prostate in late-stage prostate cancer

March 8, 2002

Third dendritic cell-based immunotherapy from Northwest Biotherapeutics cleared for clinical trials

March 5, 2002

Corixa's Melacine phase III design approved

March 4, 2002

Initiation of phase II trial of MVA-HPV-IL-2 in cervical intraepithelial neoplasia

March 1, 2002

Polypeptide CASB761 described in patent

Feb. 27, 2002

WX-G250 shows antitumor activity and very good tolerance in RCC

Feb. 25, 2002

Scancell develops apoptosis-inducing and anti-growth factor antibodies

Feb. 25, 2002

Orphan drug status granted for SS1-PE38 in mesothelioma and ovarian cancer

Feb. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...